Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Christopher DelOrefice, a director of ResMed Inc, has acquired 1,083 shares of the company’s common stock through Restricted Stock Units, which will vest by the end of 2025 or at the next annual shareholder meeting. This move highlights ongoing insider involvement and confidence in ResMed’s future performance.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.